Drug Type Bispecific antibody |
Synonyms |
Target- |
Mechanism- |
Active Indication- |
Inactive Indication |
Originator Organization Biomunex Pharmaceuticals SASStartup |
Active Organization- |
Inactive Organization Biomunex Pharmaceuticals SASStartup |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Carcinoma | Preclinical | FR | Biomunex Pharmaceuticals SASStartup | - |